II.1)
Scope of the procurement
Provision of Bypassing Agents for the treatment of Haemophilia or related disorders with inhibitors
Reference number:
SJH/ BLOOD
33141530
-
Blood coagulants
Supplies
II.1.4)
Short description
Provision of Bypassing Agents for the treatment of Haemophilia or related disorders with inhibitors
This procurement process is being undertaken by the Board of St James’s Hospital, James Street Dublin 8 on behalf of the CA. For clarity the primary customer and the contract holder will be the Board of St James’s Hospital. The CA reserves the right without advance notice (and without giving reasons, unless so required) to amend or otherwise change the process or to terminate the process. This ITT document does not represent a commitment to enter into any contract.
There will be two lots.
Lot 1 – Plasma Derived Product
Lot 2 – Recombinant Product
II.1.5)
Estimated total value
Value excluding VAT: 9000000.00
EUR
II.1.6)
Information about lots
This contract is divided into lots:
yes
Tenders may be submitted for
all lots
Plasma Derived Product
Lot No:
1
II.2.2)
Additional CPV code(s)
33141510
-
Blood products
33141570
-
Human blood
33194220
-
Blood-transfusion supplies
33600000
-
Pharmaceutical products
II.2.3)
Place of performance
Main site or place of performance:
James Street
II.2.4)
Description of the procurement
This procurement process is being undertaken by the Board of St James’s Hospital, James Street Dublin 8 on behalf of the CA. For clarity the primary customer and the contract holder will be the Board of St James’s Hospital. The CA reserves the right without advance notice (and without giving reasons, unless so required) to amend or otherwise change the process or to terminate the process. This ITT document does not represent a commitment to enter into any contract.
There will be two lots.
Lot 1 – Plasma Derived Product
Lot 2 – Recombinant Product
Value excluding VAT: 2000000.00
EUR
II.2.7)
Duration of the contract, framework agreement or dynamic purchasing system
Duration in months:
48
This contract is subject to renewal:
no
II.2.10)
Information about variants
Variants will be accepted:
yes
II.2.11)
Information about options
Options:
no
II.2.13)
Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
no
Recombinant Product
Lot No:
2
II.2.2)
Additional CPV code(s)
33141510
-
Blood products
33141570
-
Human blood
33194220
-
Blood-transfusion supplies
33600000
-
Pharmaceutical products
II.2.3)
Place of performance
Main site or place of performance:
James Street
II.2.4)
Description of the procurement
This procurement process is being undertaken by the Board of St James’s Hospital, James Street Dublin 8 on behalf of the CA. For clarity the primary customer and the contract holder will be the Board of St James’s Hospital. The CA reserves the right without advance notice (and without giving reasons, unless so required) to amend or otherwise change the process or to terminate the process. This ITT document does not represent a commitment to enter into any contract.
There will be two lots.
Lot 1 – Plasma Derived Product
Lot 2 – Recombinant Product
Value excluding VAT: 7000000.00
EUR
II.2.7)
Duration of the contract, framework agreement or dynamic purchasing system
Duration in months:
48
This contract is subject to renewal:
no
II.2.10)
Information about variants
Variants will be accepted:
yes
II.2.11)
Information about options
Options:
no
II.2.13)
Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
no